Skip to content
E2 · Observational studyCohortPEM unclearCross-sectionalPeer-reviewed
Standard · 3 min

Gray matter volume reduction in the chronic fatigue syndrome.

de Lange, Floris P, Kalkman, Joke S, Bleijenberg, Gijs et al.

NeuroImage2005DOIPubMed

Design
Cross-sectional
Participants
Not reported
PEM required
Unclear
Case definition
Not stated in the abstract

Quick Summary

This study used specialized brain imaging (MRI scans) to look for physical differences in the brains of people with ME/CFS compared to healthy people. Researchers found that ME/CFS patients had noticeably less gray matter (the part of the brain that processes information) than controls. The amount of gray matter loss was related to how much physical activity patients could manage, suggesting a real brain-based component to this illness.

Why It Matters

This study provides objective, quantifiable evidence of structural brain changes in ME/CFS, supporting the biological basis of the illness rather than a purely psychological etiology. For patients, it offers neuroimaging validation that ME/CFS involves real brain pathology; for researchers, it demonstrates a measurable biomarker that could eventually aid diagnosis and help track disease progression.

Observed Findings

What the study reports it measured.

  • Significant global gray matter volume reduction in both ME/CFS patient cohorts compared to matched healthy controls
  • Gray matter volume loss correlated with reduced physical activity levels in CFS patients
  • Structural cerebral abnormalities detected using voxel-based morphometry, an automated and unbiased technique
  • Findings were consistent across two independent patient cohorts, suggesting reproducibility

Inferred Conclusions

What the authors interpret from those results.

  • The central nervous system plays a key role in ME/CFS pathophysiology
  • Structural brain imaging may serve as an objective and quantitative diagnostic tool for ME/CFS
  • The relationship between gray matter reduction and activity limitation suggests neurobiological underpinning of core CFS symptoms

Remaining Questions

  • Is gray matter reduction a primary cause of ME/CFS or a secondary consequence of prolonged illness and reduced physical activity?
  • Do gray matter volumes change over the course of illness, and could serial imaging track disease progression or recovery?
  • Which specific brain regions show the most significant volume reduction, and how do these regional changes correlate with individual symptom profiles?
  • Can neuroimaging abnormalities predict treatment response or clinical outcomes?

What This Study Does Not Prove

The study does not establish whether gray matter reduction is a cause or consequence of ME/CFS—it is correlational evidence only. It cannot explain the mechanism behind these changes, and the cross-sectional design prevents determination of whether gray matter loss develops during illness onset or changes over time. Additionally, the relatively small sample size limits generalizability.

Explore further

About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →

Cite this study

The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.

Primary citation

de Lange, Floris P, Kalkman, Joke S, Bleijenberg, Gijs, Hagoort, Peter, van der Meer, Jos W M, & Toni, Ivan (2005). Gray matter volume reduction in the chronic fatigue syndrome.. NeuroImage. https://doi.org/10.1016/j.neuroimage.2005.02.037

BibTeX

@article{mecfsatlas-de-lange-2005-gray-matter,
  author  = {de Lange, Floris P and Kalkman, Joke S and Bleijenberg, Gijs and Hagoort, Peter and van der Meer, Jos W M and Toni, Ivan},
  title   = {Gray matter volume reduction in the chronic fatigue syndrome.},
  journal = {NeuroImage},
  year    = {2005},
  doi     = {10.1016/j.neuroimage.2005.02.037},
  note    = {PubMed: 15955487},
  url     = {https://www.mecfsatlas.com/evidence/de-lange-2005-gray-matter},
}

Atlas snapshot reference

ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-13. https://www.mecfsatlas.com/evidence/de-lange-2005-gray-matter

Contribute

Private, reviewed by a human. Not a public comment thread.